Concepedia
Statistics
Publications
81
Citations
11.2K
H-Index
42
Active since
1982
Affiliations
Center for Drug Evaluation and Research(Current)
United States Food and Drug Administration
Center for Biologics Evaluation and Research
Massachusetts Institute of Technology
Janet Woodcock is an author at Center for Drug Evaluation and Research specializing in medicine, health policy, and pharmacology.
Top concepts
MedicinePharmacologyHealth PolicyPublic HealthDrug DiscoveryPharmacotherapyHealthPatient SafetyClinical TrialsDrug Development
Publications per year
1982–2023
Real-World Evidence — What Is It and What Can It Tell Us?
Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan et al. · New England Journal of Medicine · 2016 · 1.9K citations
Healthcare Monitoring Systems, Engineering, Ehr Systems +24
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock, Lisa M. LaVange · New England Journal of Medicine · 2017 · 926 citations · Full text
Master Protocols, Disease Management, Preventive Medicine +8
Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production
Sau L. Lee, Thomas O’Connor, Xiaochuan Yang et al. · Journal of Pharmaceutical Innovation · 2015 · 832 citations · Full text
Pharmaceutical Formulation, Industrial Design, Pharmaceutical Supply Chain +5
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 613 citations · Full text
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 612 citations
Chondroitin Sulfate, Adverse Clinical Events, Pharmacology +4
1–5 of 81